Orizuru Therapeutics
R&D-driven company developing iPSCs to cure life-threatening diseases with large unmet needs.
Launch date
Employees
Fujisawa Kanagawa Prefecture (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
N/A | Series A | ||
N/A | Seed | ||
N/A | $10.3m | Early VC | |
Total Funding | $10.3m |